For following the competition: what moved in each program, several studies read as one move.
- pasritamig
- Anti-PSMA/Anti-CD28 Bispecific Antibody JNJ-87189401
- luxdegalutamide
- + 12 more
Mondays · ranked, phase 3 first · readouts ahead · See a sample brief
Add Prostatic Neoplasms, Castration-Resistant to watchlistEvery Monday by email · turn it off any timePro · free during the beta